Nebulized Albuterol Delivery in a Model of Spontaneously Breathing Children With Tracheostomy

References

1. 1.↵
   1. Willis D,
   2. Berlinski A

   . Survey of aerosol delivery techniques to spontaneously breathing tracheostomized children. Respir Care 2012;57(8)1234-1241.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Amirav I,
   2. Newhouse MT

   . Aerosol therapy in tracheotomized children: time for guidelines! Respir Care 2012;57(8):1350.

   OpenUrlFREE Full Text
3. 3.↵
   1. O'Callaghan C,
   2. Dryden S,
   3. Cert DN,
   4. Gibbin K

   . Asthma therapy and a tracheostomy. J Laryngol Otol 1989;103(4):427-428.

   OpenUrlPubMed
4. 4.
   1. Subhedar NV,
   2. Doyle C,
   3. Shaw NJ

   . Administration of inhaled medication via a tracheostomy in infants with chronic lung disease of prematurity. Pediatr Rehabil 1999;3(2):41-42.

   OpenUrlPubMed
5. 5.
   1. Monksfield P

   . Modification of a spacer device for paediatric tracheostomy. Clin Otolaryngol 2008;33(2):193-194.

   OpenUrlPubMed
6. 6.
   1. Webber PA,
   2. Brown AR

   . The use of a conical spacer after laryngectomy. BMJ (Clin Res Ed) 1984;288(6429):1537.

   OpenUrlFREE Full Text
7. 7.
   1. Nakhla V

   . A homemade modification of a spacer device for delivery of bronchodilator or steroid therapy in patients with tracheostomies. J Laryngol Otol 1997;111(4):363-365.

   OpenUrlPubMed
8. 8.
   1. Mirza S,
   2. Hopkinson L,
   3. Malik TH,
   4. Willatt DJ

   . The use of inhalers in patients with tracheal stomas or tracheostomy tubes. J Laryngol Otol 1999;113(8):762-764.

   OpenUrlPubMed
9. 9.
   1. Meeker DP,
   2. Stelmach K

   . Modification of the spacer device. Chest 1992;102(4):1243-1244.

   OpenUrlCrossRefPubMed
10. 10.
    1. García Pachón E,
    2. Casan P,
    3. Sanchís J

    . [Bronchodilators through tracheostomy]. Med Clin (Barc) 1992;99(10):396-397. Article in Spanish

    OpenUrlPubMed
11. 11.
    1. Newhouse MT

    . Hemoptysis due to MDI therapy in a patient with permanent tracheostomy: treatment with mask AeroChamber. Chest 1999;115(1):279-282.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Nandapalan V,
    2. Currey M,
    3. Jones TM

    . A modified spacer device for inhalational drug therapy for chronic bronchitis/asthma in laryngectomised patients. Clin Otolaryngol 2000;25(2):118-119.

    OpenUrlPubMed
13. 13.↵
    1. Berlinski A,
    2. Chavez A

    . Albuterol delivery via metered dose inhaler in a spontaneously breathing pediatric tracheostomy model. Pediatric Pulmonology 2013;48(10):1026-1034.

    OpenUrlPubMed
14. 14.↵
    1. Piccuito CM,
    2. Hess DR

    . Albuterol delivery via tracheostomy tube. Respir Care 2005;50(8):1071-1076.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Ari A,
    2. Harwood R,
    3. Sheard M,
    4. Fink JB

    . An in-vitro evaluation of aerosol delivery through tracheostomy and endotracheal tubes using different interfaces. Respir Care 2012;57(7):1066-1070.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Pitance l,
    2. Vecellio L,
    3. Delval G,
    4. Reychler G,
    5. Reychler H,
    6. Liistro G

    . Aerosol delivery through tracheostomy tubes: an in-vitro study. J Aerosol Med Pulm Drug Deliv 2013;26(2):76-83.

    OpenUrlPubMed
17. 17.↵
    1. Berlinski A,
    2. Hayden JB

    . Optimization of a procedure used to measure aerosol characteristics of nebulized solutions using a cooled next generation impactor. J Aerosol Med Pulm Drug Deliv 2010,23(6)397-404.

    OpenUrlPubMed
18. 18.↵
    1. Barry PW,
    2. O'Callahan C

    . An in-vitro analysis of the output of salbutamol from different nebulizers. Eur Respir Care 1999;13(5):1164-1169.

    OpenUrl
19. 19.↵
    1. Chavez A,
    2. Holt S,
    3. Heulitt M,
    4. Berlinski A

    . Albuterol delivery via mdi/spacer in a spontaneously breathing pediatric tracheostomy model: does bagging improve drug delivery? (abstract) Am J Respir Crit Care Med 2011;183(Suppl):A3383.

    OpenUrl
20. 20.↵
    1. Ahrens RC,
    2. Ries RA,
    3. Popendorf W,
    4. Wiese JA

    . The delivery of therapeutic aerosols through endotracheal tubes. Pediatr Pulmonol 1986;2(1):19-26.

    OpenUrlPubMedWeb of Science
21. 21.↵
    1. Chavez A,
    2. McCraken A,
    3. Berlinski A

    . Effect of face mask static dead volume, respiratory rate and tidal volume on inhaled albuterol delivery. Pediatr Pulmonol 2010;45(3):224-229.

    OpenUrlPubMed
22. 22.↵
    1. Chua HL,
    2. Collis GG,
    3. Newbury AM,
    4. Chan K,
    5. Bower GD,
    6. Sly PD,
    7. Le Souef PN

    . The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J 1994;7(12):185-191.

    OpenUrl
23. 23.↵
    1. O'Riordan TG,
    2. Palmer LB,
    3. Smaldone GC

    . Aerosol deposition in mechanically ventilated patients. Optimizing nebulizer delivery. Am J Respir Crit Care Med 1994;149(1):214-219.

    OpenUrlPubMedWeb of Science
24. 24.↵
    1. Berlinski A,
    2. Hayden J

    . Aerosol characteristics of 7% nebulized hypertonic saline delivered by 4 different nebulizers. Pediatr Pulmonol 2011;34(Suppl):336.

    OpenUrl
25. 25.↵
    1. Fok TF,
    2. Al-Essa M,
    3. Monkman S,
    4. Dolovich M,
    5. Girard L,
    6. Coates G,
    7. Kirpalani H

    . Pulmonary deposition of salbutamol aerosol delivered by metered dose inhaler, jet nebulizer, and ultrasonic nebulizer in mechanically ventilated rabbits. Pediatr Res 1997;42(5):721-727.

    OpenUrlPubMedWeb of Science